Galen-N

Their core work

Galen-N is a Sofia-based private research SME specialising in natural products chemistry, with hands-on expertise in isolating, characterising, and formulating bioactive compounds from aromatic plants and medicinal herbs. Their work spans the full chain from raw plant material — including processing by-products and waste streams — through phytochemical analysis to finished formulations for cosmeceuticals, food supplements, and topical skincare products. More recently they have extended into ethnobotanical documentation, drawing on traditional herbal knowledge across European cultures to identify leads for treating skin disorders and related conditions. They operate as a specialist research contributor in international consortia, bringing laboratory and formulation expertise in exchange for access to broader scientific networks.

What they specialise in

How they've shifted over time

In their first H2020 project (EXANDAS, 2016–2020) Galen-N was focused on the applied chemistry end of the spectrum — turning aromatic plant by-products into commercially usable cosmeceuticals and food supplements using eco-friendly extraction and processing technologies. When they joined EthnoHERBS in 2019, the emphasis shifted upstream toward ethnobotanical fieldwork, biodiversity documentation, and traditional knowledge as a discovery engine for new herbal actives, with skin disorders emerging as a specific therapeutic target. The trajectory is a deliberate deepening: from processing known plant materials more efficiently, toward finding new plant-based actives through cultural and ecological knowledge systems.

Galen-N appears to be building toward ethnopharmacology — bridging traditional herbal knowledge with modern phytochemical validation — which positions them well for future collaborations in natural skincare, biodiversity-linked drug discovery, or EU Green Deal-aligned bio-economy projects.

How they like to work

Galen-N has participated exclusively as a consortium partner, never as project coordinator, which is consistent with an SME that contributes focused scientific expertise rather than project management capacity. Their two MSCA-RISE projects each involve substantial consortia — 22 unique partners across 12 countries from just two projects — suggesting they are comfortable operating inside large, geographically diverse research networks. The MSCA-RISE format also implies regular staff exchanges, meaning they are likely experienced at integrating visiting researchers and sending their own staff to partner institutions, which makes day-to-day collaboration with them relatively straightforward.

Galen-N has built a surprisingly broad network for a two-project SME: 22 distinct consortium partners spread across 12 countries, all through MSCA-RISE staff-exchange programmes. Their connections are likely concentrated in Southern and Eastern European countries with strong ethnobotanical and aromatic-plant traditions, though the exact country composition is not specified in the available data.

What sets them apart

Galen-N occupies an unusual niche as a Bulgarian private-sector SME active in natural products research — a space dominated by universities and public institutes — which gives them the agility of a company combined with scientific depth in phytochemistry. Their dual competency in both the applied side (formulating cosmeceuticals and food supplements from plant by-products) and the discovery side (ethnobotanical knowledge mining) means they can contribute meaningfully at multiple points in the value chain from raw botanical material to finished product. For consortium builders, they represent a credible bridge between Eastern European biodiversity and plant heritage and Western European cosmetic and health markets.

Highlights from their portfolio

• EXANDAS
  Their largest funded project (EUR 108,000) and the clearest demonstration of their applied commercial angle — turning aromatic plant processing waste into cosmeceutical and food supplement products using eco-friendly methods.
• EthnoHERBS
  A long-running project (2019–2025) linking European biodiversity conservation with traditional herbal knowledge exploitation, which marks their expansion into ethnopharmacology and positions them in a strategically relevant area for EU Green Deal and biodiversity-framework funding.